OTLK
Outlook Therapeutics·NASDAQ
--
--(--)
--
--(--)
OTLK Filings
Filing Date
Form Description
Form Type
2026-03-25
Form 8-K - Current report
Key Events
2026-03-25 · Key Events
Form 8-K - Current report
2026-03-25
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-25 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-23
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-23 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-16
Form 8-K - Current report
Key Events
2026-03-16 · Key Events
Form 8-K - Current report
2026-03-11
Form 8-K - Current report
Key Events
2026-03-11 · Key Events
Form 8-K - Current report
2026-03-10
Form 8-K - Current report
Key Events
2026-03-10 · Key Events
Form 8-K - Current report
2026-03-05
Form 8-K - Current report
Key Events
2026-03-05 · Key Events
Form 8-K - Current report
2026-02-18
Form 8-K - Current report
Key Events
2026-02-18 · Key Events
Form 8-K - Current report
2026-02-17
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-17 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-02-17
Form 8-K - Current report
Key Events
2026-02-17 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
